Maria Agapito1, Nadia Mian, Nadka I Boyadjieva, Dipak K Sarkar. 1. Endocrine Program, Department of Animal Sciences, Graduate Program of Neuroscience, Rutgers, The State University of New Jersey, New Brunswick, New Jersey 08901, USA.
Abstract
BACKGROUND: Ethanol exposure during early life has been shown to permanently alter the circadian expression of clock regulatory genes and the beta-endorphin precursor proopiomelanocortin (POMC) gene in the hypothalamus. Ethanol also alters the stress- and immune-regulatory functions of beta-endorphin neurons in laboratory rodents. Our aim was to determine whether the circadian clock regulatory Per2 gene modulates the action of ethanol on beta-endorphin neurons in mice. METHODS: Per2 mutant (mPer2(Brdml)) and wild type (C57BL/6J) mice were used to determine the effect of Per2 mutation on ethanol-regulated beta-endorphin neuronal activity during neonatal period using an in vitro mediobasal hypothalamic (MBH) cell culture model and an in vivo milk formula feeding animal model. The beta-endorphin neuronal activity following acute and chronic ethanol treatments was evaluated by measuring the peptide released from cultured cells or peptide levels in the MBH tissues, using enzyme-linked immunosorbent assay (ELISA). RESULTS: Per2 mutant mice showed a higher basal level of beta-endorphin release from cultured MBH cells and a moderate increase in the peptide content in the MBH in comparison with control mice. However, unlike wild type mice, Per2 mutant mice showed no stimulatory or inhibitory beta-endorphin-secretory responses to acute and chronic ethanol challenges in vitro. Furthermore, Per2 mutant mice, but not wild type mice, failed to show the stimulatory and inhibitory responses of MBH beta-endorphin levels to acute and chronic ethanol challenges in vivo. CONCLUSIONS: These results suggest for the first time that the Per2 gene may be critically involved in regulating beta-endorphin neuronal function. Furthermore, the data revealed an involvement of the Per2 gene in regulating beta-endorphin neuronal responses to ethanol.
BACKGROUND:Ethanol exposure during early life has been shown to permanently alter the circadian expression of clock regulatory genes and the beta-endorphin precursor proopiomelanocortin (POMC) gene in the hypothalamus. Ethanol also alters the stress- and immune-regulatory functions of beta-endorphin neurons in laboratory rodents. Our aim was to determine whether the circadian clock regulatory Per2 gene modulates the action of ethanol on beta-endorphin neurons in mice. METHODS:Per2 mutant (mPer2(Brdml)) and wild type (C57BL/6J) mice were used to determine the effect of Per2 mutation on ethanol-regulated beta-endorphin neuronal activity during neonatal period using an in vitro mediobasal hypothalamic (MBH) cell culture model and an in vivo milk formula feeding animal model. The beta-endorphin neuronal activity following acute and chronic ethanol treatments was evaluated by measuring the peptide released from cultured cells or peptide levels in the MBH tissues, using enzyme-linked immunosorbent assay (ELISA). RESULTS:Per2 mutant mice showed a higher basal level of beta-endorphin release from cultured MBH cells and a moderate increase in the peptide content in the MBH in comparison with control mice. However, unlike wild type mice, Per2 mutant mice showed no stimulatory or inhibitory beta-endorphin-secretory responses to acute and chronic ethanol challenges in vitro. Furthermore, Per2 mutant mice, but not wild type mice, failed to show the stimulatory and inhibitory responses of MBH beta-endorphin levels to acute and chronic ethanol challenges in vivo. CONCLUSIONS: These results suggest for the first time that the Per2 gene may be critically involved in regulating beta-endorphin neuronal function. Furthermore, the data revealed an involvement of the Per2 gene in regulating beta-endorphin neuronal responses to ethanol.
Authors: Hiromi Sakata-Haga; Hector D Dominguez; Hiroyoshi Sei; Yoshihiro Fukui; Edward P Riley; Jennifer D Thomas Journal: Alcohol Clin Exp Res Date: 2006-05 Impact factor: 3.455
Authors: P C Konturek; J W Konturek; M Cześnikiewicz-Guzik; T Brzozowski; E Sito; S J Konturek Journal: J Physiol Pharmacol Date: 2005-12 Impact factor: 3.011
Authors: David A Blizard; David J Vandenbergh; Akilah L Jefferson; Cynthia D Chatlos; George P Vogler; Gerald E McClearn Journal: Alcohol Date: 2004 Oct-Nov Impact factor: 2.405
Authors: Rainer Spanagel; Gurudutt Pendyala; Carolina Abarca; Tarek Zghoul; Carles Sanchis-Segura; Maria Chiara Magnone; Jesús Lascorz; Martin Depner; David Holzberg; Michael Soyka; Stefan Schreiber; Fumihiko Matsuda; Mark Lathrop; Gunter Schumann; Urs Albrecht Journal: Nat Med Date: 2004-12-19 Impact factor: 53.440
Authors: Jascha B Pohl; Alfredo Ghezzi; Linda K Lew; Roseanna B Robles; Lawrence Cormack; Nigel S Atkinson Journal: Alcohol Clin Exp Res Date: 2013-06-28 Impact factor: 3.455
Authors: Dipak K Sarkar; Omkaram Gangisetty; Jeffrey R Wozniak; Judith K Eckerle; Michael K Georgieff; Tatiana M Foroud; Leah Wetherill; Wladimir Wertelecki; Christina D Chambers; Edward Riley; Natalya Zymak-Zakutnya; Lyubov Yevtushok Journal: Alcohol Clin Exp Res Date: 2019-08-06 Impact factor: 3.455
Authors: J J Gamsby; E L Templeton; L A Bonvini; W Wang; J J Loros; J C Dunlap; A I Green; D Gulick Journal: Behav Brain Res Date: 2013-04-20 Impact factor: 3.332
Authors: Michael J McCarthy; Malcolm Fernandes; Henry R Kranzler; Jonathan M Covault; David K Welsh Journal: Alcohol Clin Exp Res Date: 2013-03-29 Impact factor: 3.455